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1. Introduction 
Hexokinase is associated with mitochondria in 
many tissues. A characteristic of the enzyme in some 
brain mitochondrial preparations is that total activity 
can only be assayed after treatments known to disrupt 
mitochondria, such as detergents, freeze-thaw proce- 
dures, osmotic shock, or ultrasonic energy [l-3]. The 
increase in activity after such treatment compared to 
that without treatment has been termed “latent” 
activity [2] . We report some experiments concerning 
latent hexokinase activity in skeletal muscle mitochon- 
dria. It is concluded that the latent activity may be 
developed by either fatty acid complexing agents or 
mitochondrial disruption, but that in either case the 
mechanism is related to the fact that the availability 
of substrate to the enzyme is limited in the native 
state. 
2. Experimental 
2.1. Preparation of mitochondria 
Mitochondria were prepared by homogenizing 20 
g of finely-chopped chicken Pectoralis major muscle 
in 150 ml of cold 0.25 M sucrose - 15 mM histidine 
@H 7.0) solution for 25-30 set at maximal speed, 
An additional 150 ml of the sucrose-histidine solution 
was added, and the homogenate was strained through 
cheesecloth. All operations were carried out at O-4’. 
The filtrate was centrifuged for 15 min at 1600 rpm 
in the No. 269 rotor of an IEC model PR-6 centrifuge. 
The supernatant fraction was saved. The residue was 
resuspended twice in the homogenizing medium and cen- 
trifuged for 15 min as above but at 2100 rpm and 3000 
rpm, and the supernatant fractions saved. The com- 
bined supernatant fractions were centrifuged for 1 hr 
at 10,000 rpm in a GSA rotor in a Sorvall RC-2 cen- 
trifuge, The residue was resuspended in 80 ml of the 
sucrose-histidine sollition and centrifuged for 5 min 
at 2250 rpm in the SS-34 rotor in the Sorvall centrifuge. 
This residue was discarded. The supernatant fraction 
was centrifuged as above for 30 min at 11,000 rpm. 
The final reddish-brown Pellet was resuspended in a 
volume of the sucrose-histidine solution to give a 
final concentration of 15-20 mg protein per ml. The 
control sample was, therefore, in isotonic (0.25 M) 
sucrose and 15 mM histidine. All substances added to 
develop latent hexokinase activity were in addition to 
the sucrose-histidine. 
2.2. Development of latent hexokinase activity 
The mitochondrial suspension was diluted 1:5 in 
the sucrose-histidine solution (control) or the solu- 
tion to which the indicated agents were added, and 
then assayed. The mitochondrial suspension treated 
with ultrasonic oscillations was also in 0.25 M sucrose - 
15 mM histidine solution. Energy was supplied with a 
Branson Sonifier Model S-75 at maximal power (2-4 
amps) without frothing for 3 ten set intervals with 
30 set pauses to eliminate temperature increase. The 
sample was kept in an ice-water bath during this treat- 
ment and was immediately assayed. 
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2.3, Inhibition of hexokinase by fatty acids Table 1 
Development of latent hexokinase activity in skeletal muscle 
mitochondria. 
Fatty acids were dissolved in 0.25 M sucrose- 15 
mM histidine at an alkaline pH with the aid of ultra- 
sonic oscillations, and the pH was then adjusted to 
7.0. The quantities of fatty acids used were such as to 
give the final concentrations indicated. The mitochon- 
drial suspension was diluted 1:5 either with this fatty 
acid solution or sucrose-histidine (control). They 
were then assayed for hexokinase. To study the pre- 
vention of fatty acid inhibition, the appropriate 
agents were incorporated into the diluting solutions, 
or ultrasonic energy was applied to the diluted mito- 
chondrial suspension. 
Treatment 
Latent hexokinase 
activity developed 
2.4. Hexo kinase assay 
Control 
1.3% Tween 80 in 0.1 N KC1 
0.5% Triton X-100 
Ultrasonics 
1% BSA 
0.5% Triton X-100 + 1% BSA 
+ Ultrasonics 
100 
133 (8) 
118 (8) 
123 (10) 
111 (8) 
120 (3) 
Hexokinase activity was determined spectrophoto- 
metrically at 340 nm by coupling to the reduction of 
NADP+ by glucose&phosphate dehydrogenase at 30” 
in a Beckman DU-2 spectrophotometer. The reaction 
medium contained 0.1 M glucose, 20 mM MgCl, , 
5 mM ATP, 0.1 mM NADP’, 0.2 M Tris buffer, pH 7.4; 
and 0.5 units of glucose-6-phosphate dehydrogenase 
in a final volume of 1 .O ml. 
The activities are expressed as percentages of the control. The 
number in parentheses refers to the number of preparations 
assayed. 
As shown in table 2, approximately 50% of the mito- 
chondrial hexokinase activity could be inhibited by 
oleate. Octanoate had little effect; in fact at a concen- 
tration of 50 mM in the diluting medium, octanoate 
produced a slight stimulation. Triton X-100 was able 
3. Results 
The summary of our results on the effect of various 
agents and conditions on the development of latent 
activity is presented in table 1. All samples were pro- 
cessed in isotonic sucrose (0.25 M); therefore the 
effects observed are not due to osmotic shock. The 
latent activity developed by the BSA was less than the 
other treatments. This difference was statistically sig- 
nificant (p < 0.02 compared to the Triton X-100 
sample, the next highest one). With the skeletal muscle 
mitochondrial system, BSA has a positive effect on 
the development of hexokinase latency that is not 
simply due to osmotic lysis. The combination of Triton 
X-100, BSA, and treatment with ultrasonic oscillations 
did not increase the latent activity development over 
that of Triton X-100 or ultrasonic treatment alone, 
which is consistent with the results of Craven et al. 
[4] with brain mitochondria. 
Table 2 
Effect of fatty acid on mitochondrial hexokinase and reversal 
of inhibition by Triton X-100 and BSA. 
Diluted in 
Relative hexokinase 
activity 
Control 100 
Oleate (mM) 
1.0 
5.0 
10.0 
50.0 
80 
66 
52 
53 
Oleate (50 mM) 
+ addition of 0.5% Triton X-100 
+ addition of 1.0% Triton X-100 
+ addition of 1 .O% BSA 
+ ultrasonic treatment 
90 
100 
73 
40 
Octanoate (mM) 
10.0 
SO.0 
100 
114 
To test the hypothesis that this effect was due to 
prevention of fatty acid inhibition, we diluted the 
mitochondria in isotonic sucrose-histidine, pH 7.0, 
in the presence of oleate and octanoate prior to assay. 
The control mitochondria were suspended in 0.25 M sucrose- 
15 mM histidine, pH 7.0, and all additions or treatment in- 
dicated were in this solution. The figures represent he aver- 
ages of 2-4 preparations. 
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to completely reverse the inhibitory effect of oleate 
while BSA at a concentration of 1% was partially 
effective. Treatment with ultrasonic energy in the 
presence of oleate caused a small increase in inhibition 
over that produced by the oleate alone. If the excess 
oleate was removed by centrifugation and the mito- 
chondria then treated with ultrasonic energy, still no 
release of the inhibition was observed (not shown in 
table). 
4. Discussion 
Craven et al. [4] diluted beef brain mitochondria 
in various reagents and found that dilution in the 
detergent Triton X-100 or 1% serum albumin developed 
the same amount of latent activity. They also observed 
that dilution with BSA had no further effect on 
development of latent hexokinase activity after the 
mitochondria had been treated by ultrasonic energy. 
On the basis of their results, they suggested that the 
development of latent hexokinase activity might be 
due to removal of the inhibition caused by free fatty 
acids released during the preparation of the mitochon- 
dria. However, these authors were not able to demon- 
strate fatty acid inhibition of their mitochondrial 
hexokinase. Wilson [2] had previously suggested that 
development of hexokinase activity required disrup- 
tion of the mitochondria, and in a latter paper Kropp 
and Wilson [S] questioned the interpretation of 
Craven et al. They explained that a 1% BSA solution 
would be hypotonic and would, therefore, disrupt the 
mitochondria by an osmotic effect. They did, in fact, 
show that dilution in water exposed the same amount 
of hexokinase activity as did a 1% BSA solution. 
We found an effect of BSA in our system that did 
not depend on osmotic lysis of the mitochondria. We 
were also able to demonstrate that oleate inhibited 
mitochondrial hexokinase activity and further that 
BSA could partially reverse the inhibition. On the basis 
of these results and the fact that BSA should not 
affect the structural integrity of mitochondria [4], 
it is reasonable to suggest hat the development of 
latency by BSA is due to its known affinity for fatty 
acids. 
Our results also strongly support the suggestion of 
Wilson (1967) that disruption of the mitochondria 
leads to the development of latent hexokinase activity, 
since treatment with ultrasonic energy released the 
latent hexokinase activity. This procedure is known to 
disrupt mitochondria [6], but it probably has no 
effect on a fatty acid-protein complex and in fact, we 
observed no release of inhibition on exposure of our 
fatty-acid-treated samples to ultrasonic oscillations. 
We suggest hat the development of latent hexokinase 
in skeletal muscle mitochondria can be achieved by 
different means, but that they are related to the fact 
that the availability of substrate to mitochondrial 
hexokinase is limited in the native state. This may be 
due to the location of hexokinase in the mitochondria 
[4, 5, 7,8] . Structural alterations of the mitochondria 
allow substrate to reach the enzyme and thus “latent 
activity” in observed. BSA works by a different means, 
presumably by binding fatty acids, since it probably 
does not disrupt mitochondria. It seems likely that 
the BSA-mediated reversal of inhibition is not caused 
by an effect on hexokinase per se since disruption of 
the mitochondria completely removes the necessity of 
adding BSA. This indicates that the fatty acids are not 
directly inhibiting hexokinase, but that BSA removes 
some restriction on the movement of substrate in in- 
tact mitochondria caused by the fatty acids. 
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